Institute Clinic of Gynaecology, Obstetrics, and Neonatology, Hospital Clínic - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Department of Pathology, CRESIB (Centre de Recerca en Salut Internacional de Barcelona) - Hospital Clínic, University of Barcelona, Barcelona, Spain.
BJOG. 2017 Feb;124(3):495-502. doi: 10.1111/1471-0528.14247. Epub 2016 Aug 9.
To evaluate whether colposcopic measurement of the lesion size at diagnosis and/or human papillomavirus (HPV) genotyping can predict the absence of dysplasia in a large loop excision of the transformation zone (LLETZ) specimen in women treated for squamous intraepithelial lesions/cervical intraepithelial neoplasia (SIL/CIN).
Prospective observational study.
Tertiary university hospital.
A cohort of 116 women who underwent LLETZ because of biopsy-proven low-grade SIL/CIN that had persisted for 2 years, or because of a high-grade SIL/CIN diagnosed in the referral visit and squamocolumnar junction completely visible (types 1 or 2, according to the International Federation of Cervical Pathology and Colposcopy, IFCPC).
After LLETZ the women were classified by histology into the study group (absence of SIL/CIN in the surgical specimen, 28/116, 24.1%) and the control group (SIL/CIN in the LLETZ specimen, 88/116, 75.9%).
The size of the lesion determined in the diagnostic colposcopy and the HPV genotype were evaluated in all women.
The lesion size was significantly smaller in the study group (25.7 ± 37.8 versus 84.5 ± 81.7 mm ; P < 0.001). A lesion size of ≤12 mm and HPV types other than 16 or 18 were associated with an absence of SIL/CIN in the LLETZ specimen (P < 0.001 and P = 0.016, respectively). On multivariate analysis only a lesion size of ≤12 mm predicted the absence of SIL/CIN (odds ratio, OR 10.6; 95% confidence interval, 95% CI 3.6-30.6; P < 0.001). A lesion size of ≤12 mm had a specificity of 90.9% (95% CI 83.0-95.3%) and a negative predictive value of 86.0% (95% CI 77.5-91.6%) to predict the absence of SIL/CIN in the surgical specimen.
Small lesion size in diagnostic colposcopy could predict the absence of SIL/CIN in the LLETZ specimen. Colposcopy measurement of lesion size prior to LLETZ may avoid unnecessary treatment.
Small lesion size in colposcopic evaluation might predict the absence of SIL/CIN in an LLETZ specimen.
评估在诊断时阴道镜下病变大小的测量和/或人乳头瘤病毒(HPV)基因分型是否可以预测接受宫颈转化区环形电切术(LLETZ)治疗的鳞状上皮内病变/宫颈上皮内瘤变(SIL/CIN)患者的 LLETZ 标本中无发育不良。
前瞻性观察性研究。
三级大学医院。
一组 116 名因活检证实的低级别 SIL/CIN 持续 2 年而接受 LLETZ 的女性,或因转诊时诊断的高级别 SIL/CIN 和完全可见的鳞柱状交界(根据国际宫颈病理和阴道镜学会,IFCPC,分为 1 型或 2 型)。
LLETZ 后,根据组织学将女性分为研究组(手术标本无 SIL/CIN,28/116,24.1%)和对照组(LLETZ 标本有 SIL/CIN,88/116,75.9%)。
评估所有女性在诊断性阴道镜检查中的病变大小和 HPV 基因型。
研究组的病变大小明显较小(25.7 ± 37.8 与 84.5 ± 81.7 mm;P < 0.001)。病变大小≤12 mm 和 HPV 类型不是 16 或 18 与 LLETZ 标本中无 SIL/CIN 相关(P < 0.001 和 P = 0.016)。多变量分析仅显示病变大小≤12 mm 可预测 SIL/CIN 缺失(比值比,OR 10.6;95%置信区间,95%CI 3.6-30.6;P < 0.001)。病变大小≤12 mm 的特异性为 90.9%(95%CI 83.0-95.3%),阴性预测值为 86.0%(95%CI 77.5-91.6%),可预测手术标本中无 SIL/CIN。
阴道镜检查中病变小可能预测 LLETZ 标本中无 SIL/CIN。LLETZ 前阴道镜下测量病变大小可能避免不必要的治疗。
阴道镜评估中小病变大小可能预示 LLETZ 标本中无 SIL/CIN。